Forest plots demonstrated that high levels of CD93 expression were closely related to adverse outcomes in patients with ACC (p = 0.027), KIRP (p = 0.018), LGG (p < 0.0001), and UVM (p < 0.0001), whereas that meant a contrary result in KIRC (p = 0.0084) and THCA (p = 0.033) (Figure 4A). Here, CD93 is linked to adrenal cortex carcinoma.